Stockscreener 앱 받기
1.97
6.49%
0.12
전일 마감가:
$1.85
열려 있는:
$1.86
하루 거래량:
66,431
Relative Volume:
0.26
시가총액:
$75.95M
수익:
$63.15M
순이익/손실:
$-40.30M
주가수익비율:
-1.1796
EPS:
-1.67
순현금흐름:
$-44.47M
1주 성능:
+19.39%
1개월 성능:
+33.11%
6개월 성능:
-32.30%
1년 성능:
-61.67%
1일 변동 폭
$1.825
$1.97
1주일 범위
$1.62
$1.97
52주 변동 폭
$0.8645
$5.395
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.97 | 75.95M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
134.38 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.53 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.55 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.02 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
Universal Media Group (OTCMKTS:UMGP) vs. TELA Bio (NASDAQ:TELA) Critical Comparison - Defense World
Wall Street Zen Downgrades TELA Bio (NASDAQ:TELA) to Sell - Defense World
Millennium Management LLC Has $183,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe - MSN
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant - MSN
Jane Street Group LLC Acquires 7,174 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio (NASDAQ:TELA) Raised to Hold at Wall Street Zen - Defense World
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 56 - GuruFocus
Tela Bio Announces Inducement Grant Under Nasdaq Listing Rule - MarketScreener
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio Grants 105,000 Shares in Options and RSUs to New Strategic Operations SVP | TELA Stock News - Stock Titan
NORTH RUN CAPITAL, LP Acquires Significant Stake in TELA Bio Inc - GuruFocus
Tela Bio at Jefferies: Strategic Moves in Hernia and Reconstruction By Investing.com - Investing.com Canada
Tela Bio Announces OviTex Inguinal Reinforced Tissue Matri’s European Debut - MSN
Northern Trust Corp Has $142,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio launches OviTex Inguinal in Europe for hernia repair By Investing.com - Investing.com South Africa
TELA Bio Launches Tissue Matrix in Europe for Inguinal Hernia Repair - marketscreener.com
Tela Bio (TELA) Debuts OviTex Inguinal Matrix in Europe | TELA Stock News - GuruFocus
TELA Bio Announces European Commercial Launch of OviTex® Inguina - GuruFocus
TELA Bio launches OviTex Inguinal in Europe for hernia repair - Investing.com Australia
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair | TELA Stock News - GuruFocus
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - The Manila Times
TELA Bio Announces European Commercial Launch of OviTex® - GlobeNewswire
European Launch: TELA Bio's Natural Hernia Repair Device Shows 98.8% Success Rate - Stock Titan
TELA Bio Appoints Jeffrey Blizard as President - GlobeNewswire
TELA Bio names Jeffrey Blizard as new president By Investing.com - Investing.com South Africa
TELA Bio Names Jeffrey Blizard as President to Drive Strategic Growth - MyChesCo
TELA Bio names Jeffrey Blizard as new president - Investing.com India
Johnson & Johnson's Former Executive Joins TELA Bio in Leadershi - GuruFocus
TELA Bio Appoints Jeffrey Blizard as President | TELA Stock News - GuruFocus
Tela Bio appoints Jeffrey Blizard as president, effective immediately - TipRanks
TELA Bio Announces Leadership Change with New President - TipRanks
TELA Bio Appoints Jeffrey Blizard as President to Drive Growth and Innovation - Nasdaq
Strategic Power Move: TELA Bio Taps J&J Executive to Accelerate MedTech Growth Strategy - Stock Titan
TELA Bio Approves Key Proposals at Annual Meeting - TipRanks
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles By Investing.com - Investing.com Nigeria
TELA Bio’s SWOT analysis: biologic innovator faces growth hurdles - Investing.com
TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference - MSN
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference | TELA Stock News - GuruFocus
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference - GlobeNewswire
TELA Bio Brings Soft-Tissue Innovation Spotlight to Jefferies Healthcare Conference 2025 - Stock Titan
Investors Still Aren't Entirely Convinced By TELA Bio, Inc.'s (NASDAQ:TELA) Revenues Despite 39% Price Jump - simplywall.st
Piper Sandler maintains TELA Bio stock at Neutral with $2 target - Investing.com Australia
Cubist Systematic Strategies LLC Acquires 15,283 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Reports Q1 2025 Growth and Product Expansion - MSN
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan - MSN
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tela Bio Inc 주식 (TELA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
1.05%
0.64%
자본화:
|
볼륨(24시간):